Tanogitran Dihydrochloride is a potent dual inhibitor of thrombin and factor Xa, primarily investigated for its therapeutic potential in treating acute coronary syndrome by preventing blood clot formation.… Read more
Tanogitran Dihydrochloride is a potent dual inhibitor of thrombin and factor Xa, primarily investigated for its therapeutic potential in treating acute coronary syndrome by preventing blood clot formation. Within this category, laboratories can access a comprehensive range of analytical tools necessary for rigorous pharmaceutical research and development. This selection includes high-quality reference standards for Tanogitran Dihydrochloride, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for conducting precise impurity profiling, method validation, and ongoing quality control during the manufacturing process. By utilizing these characterized compounds, analytical chemists can ensure accurate identification and quantification, supporting the stringent regulatory requirements needed to evaluate drug stability and safety throughout the pharmaceutical lifecycle.